{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T19:21:51Z","timestamp":1775503311142,"version":"3.50.1"},"reference-count":39,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T00:00:00Z","timestamp":1223510400000},"content-version":"vor","delay-in-days":2930,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytopathology"],"published-print":{"date-parts":[[2000,10]]},"abstract":"<jats:title>Analysis of proliferating cell fraction determined by monoclonal antibody to M1\u2010subunit ribonucleotide reductase and Ki\u201067 in relation to p53 protein expression in fine\u2010needle aspirates from non Hodgkin's lymphomas<\/jats:title><jats:p>The purpose of this study was to analyse the proliferative fraction with the monoclonal antibody M1\u2010R\u2010R to M1\u2010subunit ribonucleotide reductase and with MIB\u20101 to Ki\u201067 antigen in relation to p53 protein expression in fine needle aspirates from B\u2010cell non\u2010Hodgkin's lymphomas.<\/jats:p><jats:p>One hundred and thirty\u2010seven cases, previously diagnosed and sub\u2010typed according to the Kiel classification and characterized by immunophenotyping, were included in the study. The M\u20101 subunit ribonucleotide reductase (M<jats:sub>1<\/jats:sub>\u2010R\u2010R), Ki\u201067 and p53 antigens were detected using monoclonal antibodies on stored cytospin preparations.<\/jats:p><jats:p>There was a good correlation (<jats:italic>r\u00a0<\/jats:italic>=\u00a00.72) between Ki\u201067 and M<jats:sub>1<\/jats:sub>\u2010R\u2010R positive cell fraction in both high and low grade lymphomas. High\u2010grade lymphomas had a median percentage of M<jats:sub>1<\/jats:sub>\u2010R\u2010R\/MIB\u20101 positive cells of 53.0\/73.0 for lymphoblastic, 61.0\/52.0 for immunoblastic and 33.5\/41.0 for centroblastic lymphomas, respectively. In low grade lymphomas figures of median percentage of M<jats:sub>1<\/jats:sub>\u2010R\u2010R\/MIB\u20101 were 9.0\/15.0 for centroblastic\/centrocytic, 11.0\/9.5 for chronic lymphocytic leukaemia, 16.0\/27.0 for centrocytic and 12.0\/9.0 for immunocytomas, respectively. The median percentages of M<jats:sub>1<\/jats:sub>\u2010R\u2010R\/MIB\u20101 for high and low grade lymphomas were 37.0\/50.5 and 11.0\/12.0, respectively. In the p53 positive cases the proliferation rate as measured by staining for M<jats:sub>1<\/jats:sub>\u2010R\u2010R and MIB\u20101 was higher than in p53 negative cases, but the difference was not statistically significant.<\/jats:p><jats:p>The results show that cytospin material obtained by fine needle aspiration and stored at \u221270\u00a0\u00b0C for years can be used reliably for both peroxidase\u2010avidin\u2010biotin and three\u2010step alkaline phosphatase immunocytochemical staining. In addition, proliferation fraction determined by M<jats:sub>1<\/jats:sub>\u2010R\u2010R monoclonal antibody staining correlates well with that measured by an established marker for cell proliferation, the Ki\u201067 antibody.<\/jats:p><jats:p>However, the proliferation fraction as measured by the two antibodies differs in the various subtypes of non\u2010Hodgkin's lymphoma which indicates that they may contribute different prognostic information.<\/jats:p>","DOI":"10.1046\/j.1365-2303.2000.00234.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T14:00:46Z","timestamp":1047391246000},"page":"290-301","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of proliferating cell fraction determined by monoclonal antibody to M1\u2010subunit ribonucleotide reductase and Ki\u201067 in relation to p53 protein expression in fine\u2010needle aspirates from non\u2010Hodgkin's lymphomas"],"prefix":"10.1111","volume":"11","author":[{"given":"V.","family":"Sviatoha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rassidakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Tribukait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kleina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Skoog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/dc.2840120308","article-title":"Growth fraction in non\u2010hodgkin's lymphomas and reactive lymphadenitis determined by Ki\u201067 monoclonal antibody in fine needle aspirates","volume":"12","author":"Skoog L","year":"1995","journal-title":"Diagn Cytopathology"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hon.2900090603","article-title":"A comparative study of proliferation associated parameters in B\u2010cell non\u2010Hodgkin's lymphomas","volume":"9","author":"Rehn S","year":"1991","journal-title":"Haematol Oncol"},{"key":"e_1_2_6_4_2","first-page":"487","article-title":"MIB\u20101 (Ki\u201067) expression in Non\u2010Hodgkin's lymphomas","volume":"17","author":"Kalogeraki A","year":"1997","journal-title":"Anticancer Res"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.1997.tb00914.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950915)76:6<1059::AID-CNCR2820760621>3.0.CO;2-E"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1200\/JCO.1994.12.10.2167","article-title":"Effect of treatment on the prognostic value of S\u2010phase fraction in non\u2010Hodgkin's lymphoma","volume":"12","author":"Joensuu H","year":"1994","journal-title":"J Clin Oncology"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V90.10.4078","article-title":"Correlation between mutation in p53, p53 expression, cytogenetic, histologic type and survival in patients with B\u2010cell Non\u2010Hodgkin's lymphomas","volume":"90","author":"Koduru PK","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_9_2","first-page":"2403","article-title":"Expression of p53, p21, mdm2, Rb, bax and Ki\u201067 proteins in lymphomas of the mucosa\u2010associated lymphoid (MALT) tissue","volume":"18","author":"Stefanaki K","year":"1998","journal-title":"Anticancer Res"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.1.18"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/00313029600169423"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000333738"},{"key":"e_1_2_6_13_2","first-page":"51","article-title":"DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non\u2010Hodgkin's lymphomas","volume":"8","author":"Czader M","year":"1995","journal-title":"Modern Pathol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2303.1999.00065.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/j.1460-2075.1984.tb01897.x","article-title":"Localisation of ribonucleotide reductase in mammalian cells","volume":"3","author":"Engstr\u00f6m Y","year":"1984","journal-title":"EMBO J"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3891\/acta.chem.scand.36b-0343"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/j.1460-2075.1988.tb02987.x","article-title":"Immunocytochemical evidences for the cytoplasmic localisation and differential expression during the cell cycle of the M1 and M2 subunits of mammalian ribonucleotide reductase","volume":"7","author":"Engstr\u00f6m Y","year":"1988","journal-title":"EMBO J"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00475a007"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990080512"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(87)90019-7"},{"key":"e_1_2_6_21_2","first-page":"433","article-title":"The p53 tumour suppressor gene","volume":"351","author":"Levine A","year":"1992","journal-title":"Nature"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ajcp\/110.1.24","article-title":"Positivity of the proliferation marker Ki\u201067 in noncycling cells","volume":"110","author":"Oijen MG","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"e_1_2_6_23_2","first-page":"369","article-title":"Value of protein 53 expression in lymphoma. Its correlation with genetic mutations","volume":"42","author":"Echezarreta G","year":"1997","journal-title":"Sangre"},{"key":"e_1_2_6_24_2","first-page":"747","article-title":"How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosental Foundation Award Lecture","volume":"53","author":"Gottesman MM","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199705)55:1<1::AID-AJH1>3.0.CO;2-Y"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000227667"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711660305"},{"key":"e_1_2_6_28_2","first-page":"1","volume-title":"Monographs in Clinical Cytology, Vol 4","author":"Zajicek J","year":"1974"},{"key":"e_1_2_6_29_2","first-page":"209","article-title":"Immunocytochemical analysis and cytomorphologic diagnosis on fine\u2010needle aspirates of lymphoproliferative diseases","volume":"32","author":"Tani EM","year":"1988","journal-title":"Acta Cytol"},{"key":"e_1_2_6_30_2","first-page":"363","article-title":"Cytomorphology and immunocytochemistry of fine\u2010needle aspirates from blastic Non\u2010Hodgkin's lymphomas","volume":"33","author":"Tani E","year":"1989","journal-title":"Acta Cytol"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19980601)32:2<78::AID-CYTO2>3.0.CO;2-A"},{"key":"e_1_2_6_32_2","first-page":"12","article-title":"The role of fine\u2010needle aspiration cytology in the diagnosis of Non\u2010Hodgkin's lymphomas","volume":"2","author":"Skoog L","year":"1991","journal-title":"Diagn Oncology"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0959-8049(93)90571-V","article-title":"Prognosis of lymphoma from a fine\u2010needle aspirates","volume":"29","author":"Joensuu H","year":"1992","journal-title":"European J Cancer"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90367-4"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation\u2010associated human antigen defined by the monoclonal antibody Ki\u201067.","volume":"133","author":"Gerdes J","year":"1984","journal-title":"J Immunol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041330321"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(88)90350-3"},{"key":"e_1_2_6_38_2","first-page":"197","article-title":"Morphological and clinical significance of cell kinetics in non\u2010Hodgkin lymphomas","volume":"30","author":"Bino GD","year":"1990","journal-title":"Basic Appl Histochem"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1994.tb05246.x"},{"key":"e_1_2_6_40_2","first-page":"4\u00a0495","article-title":"Stein Kvaloy, Ruth Langholm, Trond Stokke. Prognostic Value of Lymphoma\u2010specific S\u2010Phase fraction Compared with that of Other Cell Proliferation Markers","volume":"38","author":"Harald Holte","year":"1999","journal-title":"Acta Oncologica"}],"container-title":["Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2303.2000.00234.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2303.2000.00234.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2303.2000.00234.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T18:53:18Z","timestamp":1698605598000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2303.2000.00234.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["10.1046\/j.1365-2303.2000.00234.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2303.2000.00234.x","archive":["Portico"],"relation":{},"ISSN":["0956-5507","1365-2303"],"issn-type":[{"value":"0956-5507","type":"print"},{"value":"1365-2303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}